Evaluation of breast cancer in women under 50 in a Mastology service in the Federal District, Brazil
Keywords:
breast neoplasms, mammography, mass screening, early cancer detectionAbstract
Introduction: Breast cancer is a relevant public health issue, and its incidence has increased in patients aged less than 50 years. This population usually receives a late diagnosis, which contributes with the poor prognosis of the condition.Objective: To assess the percentage of patients diagnosed with breast cancer before the age of 50 and compare them with the group that was diagnosed after the age of 50. Results: The general mean age was 54 years; 75.68% of the patients were younger than 50 years, aged between 40 and 49 years. Among the ones who were younger than 50, 35.14% were in stage T4; 55.41% underwent neoadjuvant chemotherapy; 16.22% presented distant metastasis; and 10.81%, locoregional metastasis. On the other hand, among those aged more than 50, 22.71% were in stage T4; 30.68% underwent neoadjuvant chemotherapy; 11.36% presented distant metastasis; and 6.82%, locoregional metastasis. Conclusion: Breast cancer in women aged less than 50 years in a Mastology service in the Federal District has been a matter of concern, for presenting more advanced tumors at the time of diagnosis; screening is still debatable.
Downloads
References
Organização Mundial da Saúde. Globocan 2020 (Breast). The Global Cancer Observatory. Organização Mundial da Saúde; 2020.
Urban LAB, Chala LF, Bauab SP, Schaefer MB, Santos RP, Maranhão NMA, et al. Recomendações do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem, da Sociedade Brasileira de Mastologia e da Federação Brasileira das Associações de Ginecologia e Obstetrícia para rastreamento do câncer de mama por métodos de imagem. Radiol Bras. 2017;50(4):244-9. http://dx.doi.org/10.1590/0100-3984.2017-0069
Dias ADA, Mauro MN, Puy TC, Oliveira CM, Fecury AA, Dias CAGM, et al. Atualização sobre os principais aspectos relacionados ao câncer de mama. Rev Cient Multidiscipl Núcleo Conhecim. 2017;8(11):5-17. http://dx.doi.org/10.32749/nucleodoconhecimento.com.br/saude/cancer-de-mama
Instituto Nacional de Câncer. Detecção precoce do câncer de mama. Brasil: Instituto Nacional de Câncer, Ministério da Saúde; 2020.
Instituto Nacional de Câncer. Confira as recomendações do Ministério da Saúde para o rastreamento do câncer de mama. Instituto Nacional de Câncer, Ministério da Saúde; 2019.
Instituto Nacional de Câncer. Fatores de risco para o câncer de mama. Instituto Nacional de Câncer, Ministério da Saúde; 2019.
Instituto Nacional de Câncer. Estatísticas de câncer. Instituto Nacional de Câncer, Ministério da Saúde; 2020.
Sociedade Brasileira de Mastologia. Sociedades brasileiras recomendam mamografia a partir dos 40 anos. Sociedade Brasileira de Mastologia; 2021.
Migowski A, Silva GA, Dias MBK, Diz MPE, Sant’Ana DR, Nadanovsky P. Diretrizes para detecção precoce do câncer de mama no Brasil. II - Novas recomendações nacionais, principais evidências e controvérsias. Cad Saúde Pública. 2018;34(6):1-16. https://doi.org/10.1590/0102-311X00074817
Figueiredo MB, Silva DND, Costa MCSD. Câncer de mama em mulheres com idade inferior a 40 anos em Rio Branco-Acre: percepção e aceitação. DêCiência em Foco. 2020;4(1):29-44.
Dutra MC, Rezende MA, Andrade VP, Soares FA, Ribeiro MV, Paula EC, et al. Imunofenótipo e evolução de câncer de mama: comparação entre mulheres muito jovens e mulheres na pós-menopausa. Rev Bras Ginecol Obstet. 2009;31(2):54-60. https://doi.org/10.1590/S0100-72032009000200002
Monteiro DLM, Nunes CL, Rodrigues NCP, Antunes CA, Almeida EM, Barmpas DBS, et al. Fatores associados ao câncer de mama gestacional: estudo caso-controle. Ciênc Saúde Colet. 2019;24(6):2361-9. https://doi.org/10.1590/1413-81232018245.18392017
Cardoso MDPC. Associação entre câncer de mama e uso de contraceptivos orais de mulheres em idade fértil [thesis]. Fortaleza: Universidade Federal do Ceará; 2020.
Silva DA, Silva LK, Fonseca CSM. Câncer de mama em mulheres jovens: uma avaliação do perfil clínico-epidemiológico e molecular em um centro de tratamento especializado. Braz J Health Rev. 2019;2(6):6076-87. https://doi.org/10.34119/bjhrv2n6-102
Almeida TGD, Comassetto I, Alves KMC, Santos AAP, Silva JMO, Trezza MCSF. Vivência da mulher jovem com câncer de mama e mastectomizada. Esc Anna Nery. 2015;19(3):432-8. https://doi.org/10.5935/1414-8145.20150057
Lemos NADF, Freitas-Júnior R, Moreira MAR, Silva TC, Oliveira JC, Silva CMB. Difficulties in collecting data on ductal carcinoma in situ at a population-based cancer registry.
Franzoi MA, Rosa DD, Zaffaroni F, Werutsky G, Simon S, Bines J, et al. Advanced stage at diagnosis and worse clinicopathologic features in young women with breast cancer in brazil: a subanalysis of the AMAZONA III Study (GBECAM 0115). J Glob Oncol. 2019;5:1-10. https://doi.org/10.1200/jgo.19.00263
Laila HJEA, Zenkner JRG, Araújo MC, Becker JDL, Pereira AD. Characterization of prognostic factors of breast cancer among women with this condition attended by the Brazilian unified health system in the municipality of Bagé, Rio Grande do Sul, Brazil. Mastology. 2019;29(2):64-70. https://doi.org/10.29289/2594539420190000438
Pereira HFB, Nunes GPS, Viapiana PS, Silva KLT. Profile of care in young women with breast cancer in Amazonas: 11 years study. Mastology. 2019;29(1):20-4. https://doi.org/10.29289/2594539420190000426
Magalhães GDF, Cavalcanti FP, Lima MVA, Castro RB. Evaluation of local recurrence of breast conservation surgery at the Ceará institute of cancer. Mastology. 2019;29(1):10-3. https://doi.org/10.29289/2594539420190000371
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Ana Cláudia Leite Vilela, Lucimara Priscila Campos Veras, Sérgio Eduardo Paiva Ramos, Sádia Martins de Paula Souza, Sádia Martins de Paula Souza
This work is licensed under a Creative Commons Attribution 4.0 International License.
